Letter to the Editor

Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy

Volume 34 · Issue 3 Publish Date: March 14, 2023
Full Text PDF
DOI
Zeynep Gök Sargın
Department of Gastroenterology and Hepatology Kırıkkale University Faculty of Medicine Kırıkkale Turkey
Gök Sargın, Z. (2023). Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy. Turkish Journal of Gastroenterology, 34(3), 308–309. https://doi.org/10.5152/tjg.2023.23070
Full Text PDF

Abstract

Cite this article as: Gök Sargın Z. Risk of reactivation of hepatitis B in hepatitis B surface antigen-negative and hepatitis B core antigen antibody positive patients receiving biologic therapy. Turk J Gastroenterol. 2023;34(3):308-309.
Article Info
Published In
Journal Turkish Journal of Gastroenterology
Volume / Issue Volume 34 · Issue 3
Pages 308-309
History
Published Online March 14, 2023
License
Copyright
Affiliations
Zeynep Gök Sargın
Department of Gastroenterology and Hepatology Kırıkkale University Faculty of Medicine Kırıkkale Turkey
Cite this Article
Gök Sargın, Z. (2023). Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy. Turkish Journal of Gastroenterology, 34(3), 308–309. https://doi.org/10.5152/tjg.2023.23070
Outlines